Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments
Equine Veterinary Education · 2025-05 · 37 (5) · 271-280
DOI: 10.1111/eve.14047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Education, online erschienen am 17.09.2024. Verfasst von David I. Rendle und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Recent studies report the use of a range of treatments for equine glandular gastric disease, but with all treatments, refractory disease is common. The evidence for some widely used treatments is very poor. Treatments may aim to suppress acid production (e.g. omeprazole), promote mucosal barrier function (e.g. misoprostol/sucralfate), or both. It is imperative that all treatments are combined with management to minimise known risk factors, primarily physiological and psychological stressors.
Zitieren
APA
Rendle, D. I., & Gough, S. L. (2025). Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments. Equine Veterinary Education, 37(5), 271-280. https://doi.org/10.1111/eve.14047
Vancouver
Rendle DI, Gough SL. Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments. Equine Veterinary Education. 2025;37(5):271-280. doi:10.1111/eve.14047
BibTeX
@article{Rendle2025,
author = {Rendle, David I. and Gough, Sarah L.},
title = {Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments},
journal = {Equine Veterinary Education},
year = {2025},
volume = {37},
number = {5},
pages = {271--280},
doi = {10.1111/eve.14047}
}
EUVIMED